The pharmaceutical company has issued a statement claiming that there is no evidence that the AstraZeneca vaccine causes pulmonary embolism or thrombosis. After several countries halted the use of the vaccine due to reports of it causing blood clots in several recipients, an investigation was initiated upon a specific batch, ABV5300. The vaccine batch was delivered to 17 EU member states and it has resulted that there is no evidence for the blood clot reports.
AstraZeneca stated that across EU and UK, 15 cases of deep vein thrombosis and 22 cases of pulmonary embolism were reported among those given vaccine. This statistic is however much lower than would be expected to occur naturally, stated the pharmaceutical company. With no direct indication that the vaccine has caused the side-effects, the company stated that the benefits of using it outweigh the risks.
#MaltaDaily